Boston Scientific Corp (BSX)
74.65
+0.10
(+0.13%)
USD |
NYSE |
May 17, 16:00
74.66
+0.01
(+0.01%)
After-Hours: 20:00
Boston Scientific Cash from Operations (Annual): 2.503B for Dec. 31, 2023
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 2.503B |
| December 31, 2022 | 1.526B |
| December 31, 2021 | 1.87B |
| December 31, 2020 | 1.508B |
| December 31, 2019 | 1.836B |
| December 31, 2018 | 310.00M |
| December 31, 2017 | 1.426B |
| December 31, 2016 | 1.182B |
| December 31, 2015 | 691.00M |
| December 31, 2014 | 1.269B |
| December 31, 2013 | 1.11B |
| December 31, 2012 | 1.28B |
| December 31, 2011 | 1.008B |
| December 31, 2010 | 325.00M |
| December 31, 2009 | 835.00M |
| December 31, 2008 | 1.216B |
| December 31, 2007 | 934.00M |
| Date | Value |
|---|---|
| December 31, 2006 | 1.845B |
| December 31, 2005 | 903.00M |
| December 31, 2004 | 1.804B |
| December 31, 2003 | 787.00M |
| December 31, 2002 | 736.00M |
| December 31, 2001 | 490.00M |
| December 31, 2000 | 739.00M |
| December 31, 1999 | 776.00M |
| December 31, 1998 | 293.00M |
| December 31, 1997 | 80.00M |
| December 31, 1996 | 142.00M |
| December 31, 1995 | 32.50M |
| December 31, 1994 | 68.00M |
| December 31, 1993 | 65.80M |
| December 31, 1992 | 42.50M |
| December 31, 1991 | 29.60M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Annual) Range, Past 5 Years
1.508B
Minimum
2020
2.503B
Maximum
2023
1.849B
Average
1.836B
Median
2019
Cash from Operations (Annual) Benchmarks
| ResMed Inc | 693.30M |
| Stryker Corp | 3.711B |
| Align Technology Inc | 785.78M |
| Abbott Laboratories | 7.261B |
| Axonics Inc | -2.016M |